AccuraGen Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 10

AccuraGen General Information

Description

Developer of a liquid biopsy technology designed to facilitate personalized cancer treatment. The company's technology circulates deoxyribonucleic acid from blood samples for cancer molecular diagnosis, enabling oncologists and clinicians to access sequencing-based cancer mutation.

Contact Information

Website
www.accuragen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 2720 Zanker Road
  • Suite 240
  • San Jose, CA 95134
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AccuraGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 000.00 Completed Generating Revenue
5. Debt - PPP 15-Apr-2020 000.00 Completed Generating Revenue
4. Accelerator/Incubator 14-Sep-2016 000.00 Completed Generating Revenue
3. Early Stage VC (Series B) 01-Jun-2016 0000 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 06-Feb-2015 $6.9M $6.9M Completed Startup
1. Accelerator/Incubator Completed Startup
To view AccuraGen’s complete valuation and funding history, request access »

AccuraGen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a liquid biopsy technology designed to facilitate personalized cancer treatment. The company's technology c
Biotechnology
San Jose, CA
18 As of 2023
000.00
000000 - 000 000.00

000000

rcitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute iru
00000 0000000000 000
McLean, VA
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00

000000

ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
0000000000000
South San Francisco, CA
000 As of 0000
00000
0.000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AccuraGen Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Perthera Venture Capital-Backed McLean, VA 00 000.00 00000000000 000.00
00000000 000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
0000000 Formerly Accelerator/Incubator backed San Francisco, CA 0 000000&0
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000 000000000 Angel-Backed New York, NY 00000 0000000000 00000
You’re viewing 5 of 12 competitors. Get the full list »

AccuraGen Patents

  • 101

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 53

    Granted

  • 43

    Pending

  • 000

    Expiring in next 12 mo

AccuraGen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230234047-A1 Microfluidic detection strip chip and preparation and method thereof Pending 22-Jan-2022 0000000000
US-20230210561-A1 Fetal intrauterine positioning fixation device and system thereof Pending 01-Jan-2022 000000000
US-20230165516-A1 Device for establishing an amniotic cavity access through a mother and method thereof Pending 28-Nov-2021 0000000000
US-20230348986-A1 Methods and systems for sample normalization Pending 11-Nov-2020 0000000000
CA-3189709-A1 Methods for selective cell-free nucleic acid analysis Pending 19-Aug-2020 C12N15/1003
To view AccuraGen’s complete patent history, request access »

AccuraGen Executive Team (9)

Name Title Board Seat Contact Info
Kang Ying Ph.D Co-Founder, Co-Chief Executive Officer & Chairman
George Cardoza Co-Chief Executive Officer & Board Member
Zhaohui Sun Co-Founder & Chief Information Officer
Malek Faham Ph.D Chief Scientific Officer
Li Weng Ph.D Head of Research & Development and Director
You’re viewing 5 of 9 executive team members. Get the full list »

AccuraGen Board Members (7)

Name Representing Role Since
Daniel Zabrowski Ph.D Decheng Capital Board Member 000 0000
George Cardoza AccuraGen Co-Chief Executive Officer & Board Member 000 0000
Kang Ying Ph.D AccuraGen Co-Founder, Co-Chief Executive Officer & Chairman 000 0000
Kevin Liu Junson Capital Board Member 000 0000
Victor Tong Jr. Self Board Member & Partner 000 0000
You’re viewing 5 of 7 board members. Get the full list »

AccuraGen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AccuraGen Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
QB3 Accelerator/Incubator 000 0000 000000 0
DT Capital Partners Venture Capital Minority 000 0000 000000 0
Junson Capital Impact Investing Minority 000 0000 000000 0
Nan Fung Life Sciences Venture Capital Minority 000 0000 000000 0
Pivotal Life Sciences Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial